Evidence map›Paper›PMID 41854922›Full record

ReviewEcoHealth2026

Microbial Dormancy and Reactivation in One Health: Cross-Domain Pathways and Risks.

Adil Abalkhail, Thamer Alslamah, Najeeb Ullah Khan

Abstract readReview
PubMed Publisher
In one paragraph

Review in EcoHealth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Adil AbalkhailDepartment of Public Health, College of Applied Medical Sciences, Qassim University, 52571, Buraydah, Saudi Arabia.
Thamer AlslamahDepartment of Public Health, College of Applied Medical Sciences, Qassim University, 52571, Buraydah, Saudi Arabia.
Najeeb Ullah KhanInstitute of Biotechnology and Genetic Engineering (Health Division), The University of Agriculture Peshawar, Peshawar, 25130, Pakistan. najeebkhan@aup.edu.pk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial dormancy enables microorganisms to persist under unfavourable conditions and reactivate when ecological or host environments become permissive. While dormancy supports microbial resilience, it also creates cross-domain "hidden reservoirs" that can destabilize ecosystems, amplify zoonotic risk, and sustain antimicrobial resistance (AMR). This narrative review synthesizes evidence across environmental, animal, and human systems to explain how reactivation triggers propagate through One Health pathways-for example, nutrient enrichment or warming in aquatic/soil environments → microbial revival and amplification → exposure in livestock/wildlife → human infection via food, water, aerosols, or vectors. Dormant pathogens can persist in soil, water, sediments, biofilms, and host-associated niches, frequently evading culture-based detection and re-emerging under stressors such as temperature shifts, hydrological change, malnutrition, immunosuppression, and antimicrobial exposure. Dormancy also facilitates AMR persistence through survival of tolerant subpopulations, biofilm protection, and environmental dissemination of resistance determinants. Because key cues governing dormancy-reactivation remain incompletely characterized and surveillance systems rarely target dormant states, outbreak forecasting and mitigation are often delayed. The review therefore proposes dormancy-aware One Health surveillance and response, including field-deployable molecular detection, shared data platforms, and targeted interventions at environmental and veterinary interfaces.

Indexed as

One HealthAnimalsBiofilmsEcosystemHumansZoonosesantimicrobial Resistancebiofilmsclimate Changemicrobial dormancyone Healthsurveillance

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.